Max E. Link
Nessuna posizione attualmente
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
B. Bal | M | 61 | 12 anni | |
John Caloz | M | 72 | 17 anni | |
Jeffrey Church | M | 67 | 14 anni | |
Michael Tardugno | M | 73 | 17 anni | |
Richard Danzig | M | 80 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 23 anni |
Frederick Fritz | M | 73 | 13 anni | |
Jeffrey White | M | 70 | 10 anni | |
David Truetzel | M | 67 | 14 anni | |
David O’Brien | M | 59 | 10 anni | |
Khursheed Anwer | M | 64 | 10 anni | |
Felix Kratz | M | - | 10 anni | |
Sarah Marshall | F | - | 10 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
John Cooper | M | 65 | 15 anni | |
David Hallal | M | 56 | 10 anni | |
Joseph A. Madri | M | 80 | 22 anni | |
Steven Kriegsman | M | 82 | 20 anni | |
David Brennan | M | 70 | 7 anni | |
Jaisim Shah | M | 63 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 6 anni |
Laurence Jay Korn | M | 74 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 16 anni |
Kevin J. Ontiveros | M | 63 | 3 anni | |
Mark Reynolds | M | 62 | 14 anni | |
Melvin Booth | M | 79 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 anni |
Spencer J. Volk | M | - | 4 anni | |
Yim-Pan Cheung | M | 77 | 24 anni | |
Curran Simpson | M | 62 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 9 anni |
David W. Keiser | M | 72 | 16 anni | |
Lawrence Olanoff | M | 72 | 1 anni | |
Eric Kenneth Olson | M | 60 | 7 anni | |
William A. Haseltine | M | 79 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 anni |
Anthony P. Deasey | M | 74 | 7 anni | |
Louis J. Ignarro | M | 83 | 20 anni | |
Ty Lombardi | M | 51 | 2 anni | |
Herbert H. McDade | M | 97 | 15 anni | |
Verle D. Blaha | M | - | 1 anni | |
H. Watkins | M | 71 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 anni |
John Tattory | M | 58 | 12 anni | |
John Leone | M | 77 | 9 anni | |
Kory Wentworth | M | 45 | 9 anni | |
William W. Freimuth | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 anni |
Gilles Gallant | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
Ann Margaret Veneman | F | 75 | - | |
Lisa Lejuwaan | F | - | - | |
Alberto R. Martinez | M | 74 | 10 anni | |
William Keller | M | 75 | 6 anni | |
Jack Mollen | M | 73 | 7 anni | |
Mark Day | M | 52 | 2 anni | |
John C. King | M | 49 | 9 anni | |
Gordon G. Esplin | M | 56 | - | |
Chad Lewis | M | - | - | |
Steven W. Zeiger | M | - | - | |
Pok Yu Chow | M | 71 | 16 anni | |
Mary Templeton | F | 78 | - | |
Michael V. Greco | M | 53 | 11 anni | |
Russell Clayton | M | 63 | - | |
Ben R. Shappley | M | - | - | |
Stacey M. Ambrose | F | - | - | |
Klaus Jenny | M | 82 |
University of St. Gallen
| 5 anni |
Christian Stambach | M | 54 |
Centerpulse AG
Centerpulse AG Medical SpecialtiesHealth Technology Centerpulse AG was a medical technology group, which served the reconstructive joint, spinal and dental implant markets. Its subsidiaries developed, produced and distributed medical implants and biological materials for orthopedic, spinal and dental markets worldwide. The product array included artificial joints, dental implants, spinal implants and instrumentation. The company was headquartered in Zurich, Switzerland.
Sulzer Medica
| 1 anni |
Reyn E. Gallacher | M | - | - | |
Bryan McEntire | M | 71 | - | |
Kevin L. Davis | M | 58 | - | |
Joseph Rubinfeld | M | 91 | 14 anni | |
Henry Morgan | M | 103 | 24 anni | |
Bradley G. Lorimier | M | 78 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 anni |
Evan Myrianthopoulos | M | 59 | 9 anni | |
Christopher Coughlin | M | 71 | 7 anni | |
Robert C. Young | M | 84 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 anni |
Richard Fritschi | M | 64 |
Sulzer Medica
| 4 anni |
Augustine Lawlor | M | 67 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 anni |
Richard L. Wennekamp | M | 80 | - | |
Marvin R. Selter | M | 95 | 11 anni | |
Gregory R. Liberman | M | 51 | - | |
Larry L. Mathis | M | 80 | 10 anni | |
Benjamin S. Levin | M | 46 | 12 anni | |
W. Amick | M | 81 | 9 anni | |
Thomas Miller | M | 52 | 11 anni | |
Kathleen A. McGowan | F | 63 | 4 anni | |
George T. Jue | M | 71 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 1 anni |
Barry A. Labinger | M | 60 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 anni |
Joseph M. Mahady | M | 71 | 8 anni | |
Rockford Norby | M | 89 | 18 anni | |
Andreas Rummelt | M | 67 | 11 anni | |
Jürgen Drews | M | 91 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 13 anni |
David Lopez | M | 65 | 11 anni | |
Argeris Karabelas | M | 71 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 11 anni |
Bruce Peacock | M | 72 | 11 anni | |
Tuan Ha-Ngoc | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
Robert Hooper | M | 77 | 12 anni | |
Scott Peters | M | - | 8 anni | |
M. Burns | F | 66 | 4 anni | |
Marvin E. Rosenthale | M | 90 | 20 anni | |
Alvin S. Parven | M | 83 | 19 anni | |
Jay Moyes | M | 70 | 2 anni | |
James H. Davis | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 15 anni |
Douglas O. Ebersole | M | 68 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 14 anni |
Daniel J. Levitt | M | 76 | 8 anni | |
Steven Ryder | M | 73 | 5 anni | |
Mittie Doyle | M | 59 | 3 anni | |
Rebecca Velez Frey | F | - | 5 anni | |
Romesh R. Subramanian | M | 58 | 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 97 | 97.00% |
Svizzera | 3 | 3.00% |
Regno Unito | 0 | -.--% |
Germania | 0 | -.--% |
Canada | 0 | -.--% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Max E. Link
- Contatti personali